MLH1 and mismatch repair cancer syndrome 1: MutL homolog 1 (MLH1) and MutL homolog 2 (MLH2)—proteins belonging to MMR system—have been evaluated by immunohistochemistry from patients with colorectal cancer and 10% of these patients presented MMR deficiency.